Bezditko P. A., Babak Yu. A., Saveleva A. Yu.


About the author:

Bezditko P. A., Babak Yu. A., Saveleva A. Yu.



Type of article:

Scentific article


The relationship of primary open-ange glaucoma (POAG) with hypothyroidism is currently a topical issue in ophthalmic practice. A number of researchers have noted that there is some relationship between changes in the hormonal profile of the thyroid gland and the development of POAG. The data obtained allowed us to consider thyroid disease, in particular hypothyroidism, an independent risk factor for developing PCAG. Object and methods. There were 40 patients (40 eyes) under stage I-III POAG (on the perimeter of Humphrey) with primary subclinical hypothyroidism who studied hormonal markers of thyroid function (TSH, free T3, free T4). All patients underwent photometry, biomicroscopy, gonioscopy, tonometry, ophthalmoscopy, Humphrey perimetry. Humphrey (MD, PSD) perimetry was analyzed in these patients. Results. When examining the blood of patients with PCG with primary subclinical hypothyroidism, it was found that TSH levels ranged from 4.41 to 9.45 mIU/l and averaged 6.8 ± 0.4 mIU/l, free T3 from 5.9 to 12.8 pmol/l and averaged 8.4 ± 0.5 pmol/l, free T4 from 10.6 to 22.0 pmol/l, an average of 15.0 ± 0.9 pmol/l. Patients with PCG with primary subclinical hypothyroidism have a statistically significant dependence (p <0.05) of static perimetry on TSH, T3 free and T4 free in the blood, which confirms the dependence of the degenerative process on the thyroid hormone level. The TSH level in patients with MD <-12 dB was statistically significantly higher by 23%, in patients with MD> -12 dB higher by 57% compared with patients with MD <-6 dB; the level of T3-free in patients with MD <-12 dB below 57%, in patients with MD> -12 dB lower by 92% compared with patients with MD <-6 dB; the T4-free level in patients with MD <-12 dB is lower by 50%, in patients with MD> -12 dB lower by 110% compared with patients with MD <-6 dB. The TSH level in patients with PSD (5-7.5) is higher by 15%, in patients with PSD> 7.5 higher by 45% compared with patients with PSD <4.5; the T3-free level in patients with PSD (5-7.5) is lower by 63%, in patients with PSD> 7.5 lower by 115% compared with patients with PSD <4.5; the T4-free level in patients with PSD (5-7.5) is lower by 46%, in patients with PSD> 7.5 lower by 116% compared with patients with PSD <4.5.


thyroid hormones, primary open-angle glaucoma, subclinical hypothyroidism, perimeter


  1. Urrets-Zavalía JA, Espósito E, Garay I, Monti R, Ruiz-Lascano A, Correa L, et al. The eye and the skin in endocrine metabolic diseases. Clin Dermatol. 2016;34(2):151-65.
  2. Khandelwal D, Tandon N. Overt and subclinical hypothyroidism: who to treat and how. Drugs. 2012;72(1):17-33.
  3. Almandoz JP, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am. 2012;96(2):203-21.
  4. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002 Feb;87(2):489-99.
  5. Kelderman-Bolk N, Visser TJ, Tijssen JP, Berghout A. Quality of life in patients with primary hypothyroidism related to BMI. Eur J Endocrinol. 2015;173(4):507-15.
  6. Fadeev VV, Melnichenko GA. Hipotireoz: rukovodstvo dlya vrachey. Мoskva: RKI Severo press; 2002. 216 s. [in Russian].
  7. Alekseev IB, Iomdina EN, Aliverdiev MA, Stulova AN, Nepesova OM. Zabolevaniya shchitovidnoy zhelezy i pervichnaya otkrytougol’naya glaukoma: est li svyaz? Rossiyskiy zhurnal glaukomy. 2017;16(2):63-8. [in Russian].
  8. Menconi F, Marcocci C, Marinò M. Diagnosis and classification of Graves’ disease. Autoimmun Rev. 2014;13(4-5):398-402.
  9. Thvilum M, Brandt F, Brix TH, Hegedüs L. The interrelation between hypothyroidism and glaucoma: a critical review and meta-analyses. Acta Ophthalmol. 2017;95(8):759-67.
  10. Kakigi C, Kasuga T, Wang SY, Singh K, Hiratsuka Y, Murakami A, et al. Hypothyroidism and Glaucoma in The United States. PLoS One. 2015;10(7):e133688.
  11. Simakova IL, Serdukova SA. Nekotorie aspekty sravnitelnoi kharakteristiki raznikh metodov komputernoi perimitrii. Ophtalm. vedomosti. 2015;8(2):5-9. [in Russian].
  12. Yerichev VP, Petrov SYu, Kozlova IV, Makarova AS, Reshchikova VS. Sovremennie metodi funktsionalnoi diagnostiki i monitoringa glaucomi. Chast 1. Perimetriya kak metod funktsionalnikh issledovanii. Natsionalnii jurnal glaucoma. 2015;14(2):75-81. [in Russian].
  13. Pal NI, Batalina MV, Sergeev VP. Znacheniye korotkovolnovoy perimetrii v ranney diagnostike i monitoringe glaukomy v klinicheskoy praktike meditsinskikh optometristov. Sovremennyye tekhnologii v oftal’mologii. 2017;7:68-70. [in Russian].
  14. Morgunova TB, Fadeev VV. Gipotireoz; sovremennyy printsipy diagnostiki i lecheniya. Meditsinskiy sovet. 2016;3:79-81. [in Russian].
  15. Mohart TV, Zabarovskaya ZV, Shepelkevich AP. Klinicheskaya endokrinologiya: uchebnik. Posobiye. Minsk: Ab. School; 2013. 415 s. [in Russian].
  16. Cross JM, Girkin СА, Owsley С, McGwin Jr. The association between thyroid problems and glaucoma. PLoS One. 2015;10(7): e0133688. DOI: 10.1136/bjo.2008.147165

Publication of the article:

«Bulletin of problems biology and medicine» Issue 2 (156), 2020 year, 78-82 pages, index UDK 617.7-007.681:617.754-072.7:616.441-008.64-078